6-20250909091445 JSU

Jackson State University is seeking to procure the Schrodinger Small Molecule Drug Discovery Suite Software through a sole source procurement process with Request for Purchase (RFX) number 3150006510. The software is a comprehensive molecular modeling platform designed for scientific research, offering tools for target preparation, ligand preparation, workflow automation, and virtual modeling. This procurement will provide a three-year floating license for use by faculty, staff, and students, supporting the university's Center's mission to advance drug discovery through high-performance computational resources. The university has conducted extensive market research, including searches through the Department of Finance and Administration and web-based investigations, to confirm Schrodinger, LLC as the sole manufacturer of this specific software. The total estimated cost of the software is $44,460.00, with the procurement deadline set for September 22, 2025. Any potential vendors or entities challenging the sole source designation must submit a written objection to Kimberly R. Harris, Director of Procurement Services, with documentation explaining why the procurement should not be considered a sole source acquisition.

The procurement appears to be open to all qualified vendors, with no specific set-aside designations or restrictions on organizational types mentioned in the documentation. No incumbent vendors or existing technology integration requirements are explicitly stated in the provided materials. The sole source nature of the procurement suggests that Schrodinger, LLC is the only vendor capable of meeting the university's specific technical requirements for molecular modeling software. The procurement includes negotiated academic and volume-based discounts, indicating potential flexibility in pricing. The budget range is clearly defined at $44,460.00 for the three-year license, which represents a strategic investment in computational research capabilities. Potential objectors must provide compelling evidence to challenge the sole source determination, with the university reserving the right to review and potentially modify the procurement approach based on submitted objections.